Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lentigo maligna and lentigo maligna melanoma in vivo differentiation with dermoscopy and reflectance confocal microscopy: A retrospective, multicentre study.
Guida S, Alma A, Fiorito F, Megna A, Chester J, Kaleci S, Ciardo S, Manfredini M, Rongioletti F, Perrot JL, Rubegni P, Chello C, Cantisani C, Pellacani G, Cinotti E, Farnetani F. Guida S, et al. Among authors: kaleci s. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2293-2300. doi: 10.1111/jdv.19291. Epub 2023 Jul 21. J Eur Acad Dermatol Venereol. 2023. PMID: 37357442
Dermoscopic features of trichoepithelioma: A multicentre observational case-control study conducted by the International Dermoscopy Society.
Longo C, Lippolis N, Lai M, Spadafora M, Kaleci S, Condorelli AG, Lombardi M, Pampena R, Argenziano G, Nazzaro G, Scalvenzi M, Akay BN, Broganelli P, Fargnoli MC, Paoli J, Yélamos O, Pellacani G, Borsari S, Lallas A. Longo C, et al. Among authors: kaleci s. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1253-e1255. doi: 10.1111/jdv.19262. Epub 2023 Jun 21. J Eur Acad Dermatol Venereol. 2023. PMID: 37326166 No abstract available.
Appropriateness of psychopharmacological therapies to psychiatric diagnoses in persons with autism spectrum disorder with or without intellectual disabilities: a cross-sectional analytic study.
Di Sarro R, Varrucciu N, Di Santantonio A, Natali F, Kaleci S, Bianco A, Cappai M, Lucchi F, Bertelli MO. Di Sarro R, et al. Among authors: kaleci s. Expert Opin Drug Saf. 2023 Jul-Dec;22(12):1271-1281. doi: 10.1080/14740338.2023.2172396. Epub 2023 Jan 21. Expert Opin Drug Saf. 2023. PMID: 36681385
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience.
Meschiari M, Faltoni M, Kaleci S, Tassoni G, Orlando G, Franceschini E, Burastero G, Bedini A, Serio L, Biagioni E, Melegari G, Venturelli C, Sarti M, Bertellini E, Girardis M, Mussini C. Meschiari M, et al. Among authors: kaleci s. Int J Antimicrob Agents. 2024 May;63(5):107134. doi: 10.1016/j.ijantimicag.2024.107134. Epub 2024 Mar 5. Int J Antimicrob Agents. 2024. PMID: 38453094
Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy.
Faldetta C, Kaleci S, Chester J, Ruini C, Ciardo S, Manfredini M, Guida S, Chello C, Cantisani C, Young JN, Cabral P, Gulati N, Guttman-Yassky E, Pellacani G, Farnetani F. Faldetta C, et al. Among authors: kaleci s. J Am Acad Dermatol. 2024 Feb;90(2):309-318. doi: 10.1016/j.jaad.2023.09.084. Epub 2023 Nov 19. J Am Acad Dermatol. 2024. PMID: 37988042 Free article.
120 results